SERAFINI MARTA
Publications
Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Detail
Donsante, S., Pievani, A., Palmisano, B., Finamore, M., Fazio, G., Corsi, A., et al. (2024). Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells. JCI INSIGHT, 9(5) [10.1172/jci.insight.173449]. Detail
Pievani, A., Biondi, M., Tettamanti, S., Biondi, A., Dotti, G., Serafini, M. (2024). CARs are sharpening their weapons. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 12(1) [10.1136/jitc-2023-008275]. Detail
Donsante, S., Siciliano, G., Ciardo, M., Palmisano, B., Messina, V., de Turris, V., et al. (2023). An in vivo humanized model to study homing and sequestration of Plasmodium falciparum transmission stages in the bone marrow. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 13 [10.3389/fcimb.2023.1161669]. Detail
Biondi, M., Tettamanti, S., Galimberti, S., Cerina, B., Tomasoni, C., Dotti, G., et al. (2023). Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden. Intervento presentato a: 5th European CAR T-cell meeting, Virtual, online. Detail
Awards
Research and teaching assignments
- Attivita' di insegnamento - Università degli Studi di MILANO-BICOCCA, 2020 - 2021